QLSS Diagnostics LLC is a leading company based in Irvine, CA that specializes in liver disease diagnostics and management. Their flagship product, HEPATIQ, offers a comprehensive liver test that provides six indices of liver disease from a single scan, including quantitative liver function, steatosis, steatohepatitis, portal hypertension, alcoholic hepatitis, fibrosis stage, and variceal size. With a focus on quantifying liver function rather than just assessing fibrosis, QLSS Diagnostics aims to improve disease management and predict clinical outcomes more accurately.
By utilizing advanced technology and non-invasive techniques, QLSS Diagnostics' HEPATIQ test allows for early diagnosis, staging, interventions, and monitoring of liver disease progression. Their innovative approach helps identify individuals at risk of developing complications such as ascites, variceal bleeding, hepatic encephalopathy, and liver-related death. With a commitment to improving patient outcomes, QLSS Diagnostics is at the forefront of liver disease diagnostics and aims to revolutionize the field with their cutting-edge solutions.
Generated from the website